Hsiu-Feng Tsai
Overview
Explore the profile of Hsiu-Feng Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen S, Chou M, Hsu B, Ji W, Hsu T, Tsai H, et al.
Pathog Glob Health
. 2015 Jul;
109(5):236-41.
PMID: 26184706
Legionella spp. are common in various natural and man-made aquatic environments. Recreational hot spring is frequently reported as an infection hotspot because of various factors such as temperature and humidity....
2.
Yiang G, Tsai H, Chen J, Chou P, Wu T, Liu H, et al.
Oncol Rep
. 2014 Feb;
31(4):1738-44.
PMID: 24535104
Frog ribonucleases have been demonstrated to have anticancer activities. However, whether RC-6 ribonuclease exerts anticancer activity on human embryonal carcinoma cells remains unclear. In the present study, RC-6 induced cytotoxicity...
3.
Tung M, Hsu B, Tao C, Lin W, Tsai H, Ji D, et al.
Int J Parasitol
. 2013 May;
43(9):691-6.
PMID: 23665128
Naegleria fowleri can cause primary amoebic meningoencephalitis, a rapidly developing and highly lethal infectious disease. The first confirmed case of primary amoebic meningoencephalitis in Taiwan was reported in November 2011,...
4.
Yiang G, Yu Y, Chou P, Tsai H, Chen L, Chen Y, et al.
In Vivo
. 2012 Apr;
26(3):403-9.
PMID: 22523292
Phagocytic clearance of dying cells is found in many phagocytes. It has been shown that dying cells can be phagocytosed by other phagocytic cells through autophagic or apoptotic cellular death....
5.
Yiang G, Chou P, Tsai H, Chen L, Chang W, Yu Y, et al.
Int J Mol Med
. 2012 Feb;
29(5):809-14.
PMID: 22367420
Human interleukin-15 (hIL15) exerts anticancer effects through the activities of lymphokine-activated killer (LAK) cells. However, its short half-life hinders its clinical application. Recombinant adeno-associated virus serotype 2 (rAAV2) is used...